ICICI Direct is bullish on Syngene International recommended buy rating on the stock with a target price of Rs 740 in its research report dated April 27, 2023.

Hold Syngene International; target of Rs 610: ICICI Direct

ICICI Direct recommended hold rating on Syngene International with a target price of Rs 610 in its research report dated January 25, 2023.

Syngene: Timeline for follow-through in Zoetis contract key catalyst to watch

Another growth lever to watch in manufacturing is that of the Mangalore API facility. Here the USFDA approval is expected in H2FY24.

Pharma: Is the pandemic investment template about to play out?

The return of the flu season in India and the US, and COVID-19 in China sparked more investor interest in the sector.

A portfolio of 19 stocks to stick with for a rewarding 2023

While the outlook for the new year remains clouded, MCPro builds a 19-stock portfolio that can help investors weather uncertainties

Buy Syngene International; target of Rs 710: ICICI Direct

ICICI Direct is bullish on Syngene International recommended buy rating on the stock with a target price of Rs 710 in its research report dated October 21, 2022.

Syngene: Can it keep its premium valuation, going forward?

Investment in biologics is expected to remain recurring as new opportunities are unfolding in the field of biologics for Syngene

Syngene: Multi-year contract with Zoetis adds to long-term visibility

The risk to watch is the execution in the field biologics and the pending regulatory approvals

Buy Syngene International; target of Rs 730: ICICI Direct

ICICI Direct is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 730 in its research report dated April 29, 2022.

Hikal: Green integrity in the spotlight, more than financials

We are entering increasing interest rate scenario. Liquidity is drying which simply means institutional fund flows would be much more selective and sensitive to quality aspect

Buy Syngene International; target of Rs 710: ICICI Direct

ICICI Direct is bullish on Syngene International recommended buy rating on the stock with a target price of Rs 710 in its research report dated January 21, 2022.

Buy Syngene International; target of Rs 710: ICICI Direct

ICICI Direct is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 710 in its research report dated October 22, 2021.

Syngene: Look beyond the near-term input cost pressure

Syngene continues to guide for a mid-teen revenue growth in FY22. This appears possible, given the improved demand scenario and the strong traction in H1 FY22

Buy Syngene International; target of Rs 780: ICICI Direct

ICICI Direct is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 780 in its research report dated July 22, 2021.

Syngene: Heavy investment phase makes it a long-term play

Beyond contract research, another trend to watch for Syngene is the pick-up in contract manufacturing business in biologics and APIs

CDMO leader ready to straddle entire pharma value chain

Except phosgenation and fluorination, Suven Pharma is capable of handling every other chemistry. This adds to the scope for contract engagements in speciality chemicals and clinical development for pharma

Buy Syngene International; target of Rs 700: ICICI Direct

ICICI Direct is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 700 in its research report dated January 22, 2021.

Buy Syngene International; target of Rs 640: Dolat Capital Market

Dolat Capital Market is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 640 in its research report dated January 21, 2021.

Gland Pharma Q3: Strong and clean play on global generic injectables; accumulate

We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturers

Buy Syngene International; target of Rs 635: ICICI Direct

ICICI Direct is bullish on Syngene International recommended buy rating on the stock with a target price of Rs 635 in its rch report dated October 23, 2020

Buy Syngene International; target of Rs 640: Dolat Capital Market

Dolat Capital Market is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 640 in its research report dated October 22, 2020.

Buy Syngene International; target of Rs 485: ICICI Direct

ICICI Direct is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 485 in its research report dated July 23, 2020.

Buy Syngene International; target of Rs 390: ICICI Direct

ICICI Direct is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 390 in its research report dated May 14, 2020.

Buy Syngene International; target of Rs 360: ICICI Direct

ICICI Direct is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 360 in its research report dated July 26, 2019.

Buy Syngene International; target of Rs 700: Globe Capital Market

Globe Capital Market is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 700 in its research report dated May 02, 2019.